Fisher Asset Management, LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,898,000
+41.4%
105,726
-40.9%
0.01%
+150.0%
Q1 2019$3,465,000
+175.4%
178,763
+102.6%
0.00%0.0%
Q4 2018$1,258,000
-6.2%
88,2560.0%0.00%0.0%
Q3 2018$1,341,000
-33.7%
88,256
-26.8%
0.00%
-33.3%
Q2 2018$2,023,000
-21.6%
120,576
-23.8%
0.00%0.0%
Q1 2018$2,582,000
+25.0%
158,223
-2.0%
0.00%0.0%
Q4 2017$2,066,000
+25.2%
161,433
+20.3%
0.00%
+50.0%
Q3 2017$1,650,000
+46.9%
134,1800.0%0.00%0.0%
Q2 2017$1,123,000
+61.1%
134,180
+72.0%
0.00%
+100.0%
Q1 2017$697,000
+20.8%
78,014
+18.8%
0.00%0.0%
Q4 2016$577,000
-37.1%
65,693
-51.7%
0.00%
-50.0%
Q3 2016$917,000
+80.9%
135,895
+0.1%
0.00%
+100.0%
Q2 2016$507,000
+17.9%
135,6950.0%0.00%0.0%
Q1 2016$430,000
-25.0%
135,6950.0%0.00%0.0%
Q4 2015$573,000
-7.4%
135,6950.0%0.00%0.0%
Q3 2015$619,000135,6950.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders